middle.news
OncoSil Medical Wins FDA Approval for Rare Bile Duct Cancer Device
8:35am on Monday 17th of August, 2026 AEST
•
Healthcare
Read Story
OncoSil Medical Wins FDA Approval for Rare Bile Duct Cancer Device
8:35am on Monday 17th of August, 2026 AEST
Key Points
FDA grants HDE approval for OncoSil™ in distal cholangiocarcinoma
First and only Class III device approved for this rare bile duct cancer
US addressable market estimated at 1,000 patients and A$80 million
Initial use limited to five centres under post-approval study
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE